Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05137223 · ClinicalTrials.gov registry record

BREATHE-Peds Pilot - I Focus Group Interviews

A clinical trial, sponsored by Columbia University.

Completed
Registry status
45
Enrollment target

NCT05137223 is a clinical trial that has completed, run by Columbia University. The registered enrollment target is 45 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05137223 has completed, sponsored by Columbia University.

COMPLETED
Registry status
45 participants
Enrollment target

Study Summary

The overall aims of this study are to develop and pilot test BRief intervention to Evaluate Asthma THErapy (BREATHE)-Peds, a dyadic shared decision-making intervention, to improve asthma by supporting self-management among racial and ethnic minority early adolescents receiving care for uncontrolled asthma in federally-qualified health centers (FQHCs) in urban communities. Aim 1 (Phase I) involves developing the intervention through focus groups with early adolescents and caregivers. Aims 2 and 3 (Phase II) involve preliminary testing of the intervention through a pilot randomized controlled trial. This record is for Phase I only.

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2022-04-26
Est. Completion 2022-09-19

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT05137223

The ClinicalTrials.gov registry entry for NCT05137223 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT05137223 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05137223 about?

NCT05137223 is a clinical study titled "BREATHE-Peds Pilot - I Focus Group Interviews". The overall aims of this study are to develop and pilot test BRief intervention to Evaluate Asthma THErapy (BREATHE)-Peds, a dyadic shared decision-making intervention, to improve asthma by supporting self-management among racial and ethnic minority early adolescents receiving care for uncontrolled ...

What is the current status of trial NCT05137223?

This trial is currently completed. The enrollment target is 45 participants. The study started on 2022-04-26. Estimated completion is 2022-09-19.

Who is sponsoring clinical trial NCT05137223?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.